{
    "ticker": "ONYX",
    "name": "Onyx Pharmaceuticals, Inc.",
    "description": "Onyx Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of innovative therapies for cancer and other serious diseases. Founded in 1992, Onyx has made significant strides in advancing treatments aimed at improving patient outcomes. The company is best known for its development of targeted therapies, particularly in the field of hematologic malignancies and solid tumors. Onyx's flagship product, Kyprolis (carfilzomib), is an FDA-approved treatment for multiple myeloma, demonstrating the company's commitment to addressing unmet medical needs in oncology. In addition to Kyprolis, Onyx works on a pipeline of investigational drugs that aim to harness the power of the immune system and other pathways to fight cancer more effectively. Onyx is dedicated to scientific innovation and collaborates with leading research institutions to enhance its therapeutic offerings. The company's mission is to transform the treatment landscape for cancer patients, providing them with new hope and better quality of life through advanced medical solutions.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "San Francisco, California, USA",
    "founded": "1992",
    "website": "https://www.onyx-pharm.com",
    "ceo": "N/A",
    "social_media": {
        "twitter": "https://twitter.com/OnyxPharma",
        "linkedin": "https://www.linkedin.com/company/onyx-pharmaceuticals"
    },
    "investor_relations": "https://investors.onyx-pharm.com",
    "key_executives": [
        {
            "name": "N/A",
            "position": "CEO"
        },
        {
            "name": "N/A",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Oncology Treatments",
            "products": [
                "Kyprolis"
            ]
        }
    ],
    "seo": {
        "meta_title": "Onyx Pharmaceuticals, Inc. | Innovative Cancer Therapies",
        "meta_description": "Onyx Pharmaceuticals, Inc. specializes in the development of targeted therapies for cancer. Explore Onyx's innovative products and commitment to improving patient outcomes.",
        "keywords": [
            "Onyx Pharmaceuticals",
            "Cancer Treatments",
            "Biopharmaceuticals",
            "Kyprolis",
            "Oncology"
        ]
    },
    "faq": [
        {
            "question": "What is Onyx Pharmaceuticals known for?",
            "answer": "Onyx Pharmaceuticals is known for its innovative cancer therapies, particularly its product Kyprolis for multiple myeloma."
        },
        {
            "question": "Where is Onyx Pharmaceuticals headquartered?",
            "answer": "Onyx Pharmaceuticals is headquartered in San Francisco, California, USA."
        },
        {
            "question": "When was Onyx Pharmaceuticals founded?",
            "answer": "Onyx Pharmaceuticals was founded in 1992."
        }
    ],
    "competitors": [
        "AMGN",
        "BMY",
        "MRNA",
        "GILD"
    ],
    "related_stocks": [
        "JNJ",
        "PFE",
        "ABBV",
        "NOVN"
    ]
}